HAL vs MGX · P/E 9.3, $19.05B cap vs rev $52.3M
Halliburton Company (HAL) versus Metagenomi, Inc. Common Stock (MGX) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Metagenomi, Inc. Common Stock (MGX) is a biotechnology company listed on NASDAQ.
HAL does not have a complete income-statement cache yet.
Latest reported MGX revenue for 2024-12-31 was $52.3M. Net income was -$78.1M. Revenue was up 16.8% from 2023-12-31 to 2024-12-31. MGX currently screens at market cap $44.4M.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. MGX currently screens at market cap $44.4M.
Not investment advice. Open the HAL and MGX stock pages for the full models.
Not investment advice.